查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825741

2025年全球胃扩张药物输送系统外包市场报告

Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，胃肠扩张药物输送系统外包市场规模将强劲成长，2029年将达到19.8亿美元，复合年增长率为7.4%。预测期内的增长可归因于多种因素，例如门诊中心数量的增加、对患者依从性和便利性的重视、慢性病患病率的上升、个性化医疗的普及以及人口老龄化。预测期内的主要趋势包括聚合物科学、製剂技术、生物黏附系统、新型聚合物、药物释放调节剂、胃滞留剂型的开发、数位健康技术的整合、智慧胃滞留系统以及标靶药物传递等方面的进步。

未来五年7.4%的预测成长率，较我们先前对该市场的预测略有下降，下降了0.5%。这一下降主要源自于美国与其他国家之间关税的影响。以色列和印度对浮动胶囊技术征收的关税可能会减缓缓释性的开发，尤其是抗生素和帕金森氏症药物的缓释製剂，同时也会使每种候选药物的研发成本增加200万至300万美元。由于互惠关税以及贸易摩擦和限制升级对全球经济和贸易的负面影响，其影响也将更加广泛。

胃肠道疾病的日益普及预计将推动胃肠道扩张药物输送系统外包市场的扩张。胃肠道疾病包括影响消化器官系统的多种疾病，包括胃、肝、胆囊、肠和胰臟。这些疾病的增加归因于人口老化、抗生素的使用、感染疾病、饮食变化、压力、生活方式因素和肥胖等因素。外包胃肠道扩张药物输送系统使製药公司能够获得解决日益加重的胃肠道疾病负担所需的专业知识和资源，最终改善患者的预后和生活品质。例如，美国卫生组织美国癌症协会 (ACS) 在 2023 年 1 月报告称，美国胃肠道癌症将增加 3.18%，从美国的 338,090 例增加到 348,840 例。因此，胃肠道疾病盛行率的上升正在推动胃肠道扩张药物输送系统外包市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球胃扩张药物输送系统外包：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球胃扩张药物输送系统外包市场：成长率分析
  • 全球胃扩张药物输送系统外包市场表现：规模与成长，2019-2024
  • 全球胃扩张药物输送系统外包市场预测：规模与成长，2024-2029年，2034年
  • 全球胃扩张药物输送系统外包：总目标市场（TAM）

第六章 市场细分

  • 全球胃扩张药物输送系统外包市场类型、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 浮动系统
  • 生物黏附系统
  • 其他类型
  • 全球胃扩张药物输送系统外包市场（按剂型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 药片
  • 液体
  • 微球
  • 胶囊
  • 其他剂型
  • 全球胃扩张药物输送系统外包市场的应用、效能与预测，2019-2024年、2024-2029年、2034年
  • 胃食道逆流症（GERD）
  • 神经系统疾病
  • 其他用途
  • 全球胃扩张药物输送系统外包市场（按最终用户、业绩和预测），2019-2024 年、2024-2029 年、2034 年
  • 製药公司
  • 合约研究组织（CRO）
  • 其他最终用户
  • 全球胃扩张药物输送系统外包市场：细分浮动系统（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单元系统
  • 多单元系统
  • 全球胃扩张药物输送系统外包市场：依生物黏附系统细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 水凝胶
  • 黏膜附着性聚合物
  • 全球胃扩张药物输送系统外包市场：按类型、其他、实际结果和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 磁力辅助系统
  • 高密度系统
  • 渗透系统

第七章 区域和国家分析

  • 全球胃扩张药物输送系统外包市场（按地区、绩效及预测）2019-2024年、2024-2029年、2034年
  • 全球胃扩张药物输送系统外包市场（依国家、绩效及预测）2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 胃气管扩张药物输送系统外包市场：竞争格局
  • 胃气管扩张药物输送系统外包市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • AstraZeneca plc
  • Novartis AG
  • GlaxoSmithKline plc
  • Evonik Industries AG
  • Alcon Inc.
  • SGS SA
  • Lonza Group AG
  • FMC Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • AptarGroup Inc.
  • Cadila Pharmaceuticals
  • Ashland Global Holdings Inc
  • Lupin Limited
  • Torrent Pharmaceuticals Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 胃气管扩张药物输送系统外包市场2029：提供新机会的国家
  • 胃气管扩张药物输送系统外包市场2029：细分市场提供新机会
  • 胃气管扩张药物输送系统外包市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30297u

Gastroretentive drug delivery systems outsourcing involves pharmaceutical firms engaging external service providers or contract research organizations (CROs) to create and produce drug delivery systems intended to extend the duration of medication within the gastrointestinal (GI) tract. These systems are crafted to boost drug absorption, enhance therapeutic effectiveness, and optimize patient results.

The primary categories of gastroretentive drug delivery systems outsourcing include floating systems, bioadhesive systems, and other variants. A floating drug delivery system (FDDS) is tailored to extend the retention period of medications in the stomach and upper gastrointestinal tract. These systems come in various dosage forms such as tablets, liquids, microspheres, capsules, and others, serving diverse applications such as gastroesophageal reflux disease (GERD), neurological disorders, and more. They are utilized by a range of end-users, including pharmaceutical companies, contract research organizations (CROs), and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The gastroretentive drug delivery systems outsourcing market research report is one of a series of new reports from The Business Research Company that provides gastroretentive drug delivery systems outsourcing market statistics, including gastroretentive drug delivery systems outsourcing industry global market size, regional shares, competitors with a gastroretentive drug delivery systems outsourcing market share, detailed gastroretentive drug delivery systems outsourcing market segments, market trends, and opportunities, and any further data you may need to thrive in the gastroretentive drug delivery systems outsourcing industry. This gastroretentive drug delivery systems outsourcing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastroretentive drug delivery systems outsourcing market size has grown strongly in recent years. It will grow from $1.39 billion in 2024 to $1.49 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the rising incidence of stomach and small intestine disorders, rising drug delivery systems, rising prevalence of gastric cancer, rise in government initiatives, and increase in the number of hospitals.

The gastroretentive drug delivery systems outsourcing market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increase in the number of ambulatory centers, the focus on patient compliance and convenience, the rising incidence of chronic diseases, increasing personalized medicine, and the growing aging population. Major trends in the forecast period include advancements in polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the development of gastroretentive dosage forms, the integration of digital health technologies, smart gastroretentive systems, and targeted drug delivery.

The forecast of 7.4% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on floating capsule technologies from Israel and India may delay development of extended-release formulations, particularly for antibiotics and Parkinson's medications, while increasing research and development (R&D) costs by $2-3 million per drug candidate. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of gastrointestinal disorders is expected to drive the expansion of the gastroretentive drug delivery systems outsourcing market. Gastrointestinal disorders encompass a wide range of diseases affecting the digestive system, including the stomach, liver, gallbladder, intestines, and pancreas. The rise in these disorders is attributed to factors such as aging populations, antibiotic use, infectious agents, dietary changes, stress, lifestyle factors, and obesity. Outsourcing gastroretentive drug delivery systems enables pharmaceutical companies to access the expertise and resources needed to address the increasing burden of gastrointestinal conditions, ultimately improving patient outcomes and quality of life. For instance, in January 2023, the American Cancer Society (ACS), a US-based health organization, reported a 3.18% increase in gastrointestinal cancers, rising to 348,840 cases from 338,090 in 2021 in the United States. Therefore, the rising prevalence of gastrointestinal disorders is driving the growth of the gastroretentive drug delivery systems outsourcing market.

Key players in the gastroretentive drug delivery systems outsourcing market are concentrating on developing innovative solutions, such as ready-to-fill (RTF) colon functional capsules, to improve drug delivery efficiency and enhance patient convenience. Ready-to-fill (RTF) colon functional capsules are pre-manufactured, empty capsules designed to be filled with specific formulations or active ingredients intended for targeted delivery to the colon. For example, in September 2024, Evonik, a Germany-based leader in advanced drug delivery, introduced its EUDRACAP colon functional capsules, designed to deliver oral medications directly to the ileo-colonic region. These capsules represent the first ready-to-fill option in the market, specifically intended to carry sensitive active ingredients like live biotherapeutic products (LBPs). Currently available in technical grade, a GMP-grade version is under development. EUDRACAP colon simplifies the oral drug development process by easing formulation and speeding up time to market, marking a significant step forward in gastroretentive drug delivery systems.

In August 2022, Catalent Inc., a pharmaceutical company headquartered in the United States, completed the acquisition of Metrics Contract Services (Metrics) for an estimated $475 million. Through this strategic move, Catalent intends to fortify its integrated capabilities in oral solid formulation development, manufacturing, and packaging, thereby augmenting its capacity to handle potent compounds and improving its capacity to satisfy customer demands and patient requirements. Metrics Contract Services, based in the United States, is a contract development and manufacturing organization (CDMO) that specializes in providing services for pharmaceutical product development, manufacturing, and analytical testing.

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastroretentive drug delivery systems outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gastroretentive drug delivery systems outsourcing market consists of revenues earned by entities by providing services such as analytical and testing services, formulation development, quality assurance and control, and clinical trial services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroretentive drug delivery systems outsourcing market also includes sales of bioadhesive systems, swelling systems, and high-density systems, and floating systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastroretentive drug delivery systems outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastroretentive drug delivery systems outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastroretentive drug delivery systems outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Floating Systems; Bioadhesive Systems; Other Types
  • 2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms
  • 3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications
  • 4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users
  • Subsegments:
  • 1) Floating Systems: Single Unit Systems; Multiple Unit Systems
  • 2) Bioadhesive Systems: Hydrogels; Mucoadhesive Polymers
  • 3) Other Types: Magnetically Assisted Systems; High-Density Systems; Osmotic Systems
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca plc; Novartis AG; GlaxoSmithKline plc; Evonik Industries AG; Alcon Inc.; SGS SA; Lonza Group AG; FMC Corporation; Sun Pharmaceutical Industries Ltd.; Catalent Inc.; AptarGroup Inc.; Cadila Pharmaceuticals; Ashland Global Holdings Inc; Lupin Limited; Torrent Pharmaceuticals Ltd.; Evotec SE; Colorcon Inc.; Ranbaxy Laboratories Limited; Quotient Sciences Limited; Aenova Group; Vectura Group Ltd.; Assertio Therapeutics Inc.; Coating Place Inc.; Xiromed LLC; SPI Pharma Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastroretentive Drug Delivery Systems Outsourcing Market Characteristics

3. Gastroretentive Drug Delivery Systems Outsourcing Market Trends And Strategies

4. Gastroretentive Drug Delivery Systems Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gastroretentive Drug Delivery Systems Outsourcing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Gastroretentive Drug Delivery Systems Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Gastroretentive Drug Delivery Systems Outsourcing Market Growth Rate Analysis
  • 5.4. Global Gastroretentive Drug Delivery Systems Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Gastroretentive Drug Delivery Systems Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Gastroretentive Drug Delivery Systems Outsourcing Total Addressable Market (TAM)

6. Gastroretentive Drug Delivery Systems Outsourcing Market Segmentation

  • 6.1. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Floating Systems
  • Bioadhesive Systems
  • Other Types
  • 6.2. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets
  • Liquid
  • Microspheres
  • Capsule
  • Other Dosage Forms
  • 6.3. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gastroesophageal Reflux Disease (GERD)
  • Neurological Disorders
  • Other Applications
  • 6.4. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Other End Users
  • 6.5. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Sub-Segmentation Of Floating Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Unit Systems
  • Multiple Unit Systems
  • 6.6. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Sub-Segmentation Of Bioadhesive Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hydrogels
  • Mucoadhesive Polymers
  • 6.7. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Magnetically Assisted Systems
  • High-Density Systems
  • Osmotic Systems

7. Gastroretentive Drug Delivery Systems Outsourcing Market Regional And Country Analysis

  • 7.1. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market

  • 8.1. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastroretentive Drug Delivery Systems Outsourcing Market

  • 9.1. China Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 9.2. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastroretentive Drug Delivery Systems Outsourcing Market

  • 10.1. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastroretentive Drug Delivery Systems Outsourcing Market

  • 11.1. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 11.2. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastroretentive Drug Delivery Systems Outsourcing Market

  • 12.1. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market

  • 13.1. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market

  • 14.1. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 14.2. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market

  • 15.1. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 15.2. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastroretentive Drug Delivery Systems Outsourcing Market

  • 16.1. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastroretentive Drug Delivery Systems Outsourcing Market

  • 17.1. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastroretentive Drug Delivery Systems Outsourcing Market

  • 18.1. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastroretentive Drug Delivery Systems Outsourcing Market

  • 19.1. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastroretentive Drug Delivery Systems Outsourcing Market

  • 20.1. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market

  • 21.1. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 21.2. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastroretentive Drug Delivery Systems Outsourcing Market

  • 22.1. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastroretentive Drug Delivery Systems Outsourcing Market

  • 23.1. North America Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 23.2. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastroretentive Drug Delivery Systems Outsourcing Market

  • 24.1. USA Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 24.2. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastroretentive Drug Delivery Systems Outsourcing Market

  • 25.1. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 25.2. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastroretentive Drug Delivery Systems Outsourcing Market

  • 26.1. South America Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 26.2. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market

  • 27.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market

  • 28.1. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 28.2. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastroretentive Drug Delivery Systems Outsourcing Market

  • 29.1. Africa Gastroretentive Drug Delivery Systems Outsourcing Market Overview
  • 29.2. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Landscape And Company Profiles

  • 30.1. Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Landscape
  • 30.2. Gastroretentive Drug Delivery Systems Outsourcing Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Gastroretentive Drug Delivery Systems Outsourcing Market Other Major And Innovative Companies

  • 31.1. AstraZeneca plc
  • 31.2. Novartis AG
  • 31.3. GlaxoSmithKline plc
  • 31.4. Evonik Industries AG
  • 31.5. Alcon Inc.
  • 31.6. SGS SA
  • 31.7. Lonza Group AG
  • 31.8. FMC Corporation
  • 31.9. Sun Pharmaceutical Industries Ltd.
  • 31.10. Catalent Inc.
  • 31.11. AptarGroup Inc.
  • 31.12. Cadila Pharmaceuticals
  • 31.13. Ashland Global Holdings Inc
  • 31.14. Lupin Limited
  • 31.15. Torrent Pharmaceuticals Ltd.

32. Global Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastroretentive Drug Delivery Systems Outsourcing Market

34. Recent Developments In The Gastroretentive Drug Delivery Systems Outsourcing Market

35. Gastroretentive Drug Delivery Systems Outsourcing Market High Potential Countries, Segments and Strategies

  • 35.1 Gastroretentive Drug Delivery Systems Outsourcing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Gastroretentive Drug Delivery Systems Outsourcing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Gastroretentive Drug Delivery Systems Outsourcing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer